NASH is a severe form of nonalcoholic fatty liver disease characterized by chronic inflammation and liver cell injury. 8: Chronic liver dis NEC: 573. 8. The liver makes and exports fat to other parts of the body. Case presentation A 26-year-old woman with 28 + 5. 21037/atm-20-4354. The ICD-9-CM code. NAFL is defined as the presence of 5% HS without evidence. Definition & Facts. 6 contain annotation back-references that may be applicable to K74. ICD-9: 571. Short description: Chronic liver dis NEC. 6%). Nonalcoholic Steatohepatitis (NASH): Complications. See full list on my. -); Budd-Chiari syndrome (I82. Our large population database results emphasize that there is a significant association between OSA and NASH. The 2024 edition of ICD-10-CM K74. NASH: NASH stands for Non-Alcoholic Steatohepatitis. The National Library of Medicine provides a Newborn Screening Coding and Terminology Guide. Billable Thru Sept 30/2015. Nonalcoholic fatty liver disease, or NAFLD, refers to the buildup of excess fat in the liver. Codes . 1 About 35% of patients with NASH develop progressive liver fibrosis. codes reported an incidence rate for NAFLD of 29 per 100,000 person-years. Reye syndrome (8E46) Acute fatty liver of pregnancy (JA65. Hepatitis, unspecified. 1016/j. The control group included the rest of adult individuals without discharge records of NASH. Hepatic fibrosis. 0 may differ. 8, including coding notes, detailed descriptions, index cross-references and ICD-10-CM conversion. While also a condition of fat in the liver, those with nonalcoholic steatohepatitis have liver inflammation and, usually, liver cell damage as. 01% risk of mortality. 02: Hepatic fibrosis:. Alcoholic hepatitis ranges from mild and reversible to life threatening. 81 - other international versions of ICD-10 K76. Choose Language. 0 [convert to ICD-9-CM]The recent American Heart Association Statement on non-alcoholic fatty liver disease (NAFLD) and cardiovascular risk aims to raise awareness that NAFLD should be considered as a cardiovascular risk marker and risk enhancer. 2011 Jun;54(6):1224-9. 571. The tissue sample is looked at in a lab for signs of inflammation and scarring. Although a similar. et al. 81: 571. The condition is characterised by excessive hepatic fat accumulation and is directly associated with. 500 results found. 0 [convert to ICD-9-CM]Metabolic dysfunction-associated steatohepatitis (non-alcohol related steatohepatitis) is a type of fatty liver disease that causes inflammation and liver damage. However, the prevalence and incidence of recorded NAFLD diagnoses in unselected real-world. Nonalcoholic steatohepatitis is strongly associated with overweight or obesity and the metabolic syndrome. We harmonised health records from four. 0-1. This test is a noninvasive assessment of liver status in patients with nonalcoholic fatty liver disease (NAFLD). S. A diagnosis of NAFLD (based on unexplained serum ALT elevation) was observed in 3. Non-alcoholic fatty liver disease (NAFLD) is a common, progressive liver disease strongly associated with the metabolic syndrome. Steatosis and lobular inflammation are graded 0–3 based on severity, whereas ballooning is graded 0–2. NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; NFS, NAFLD fibrosis score, NLP, natural language processing. Non-alcoholic fatty liver disease (NAFLD) is a common, progressive liver disease strongly associated with the metabolic syndrome. [2] Patients typically have a history of at least 10 years of heavy alcohol intake, typically 8-10 drinks per day. Diagnosis Code for Reimbursement Claim: ICD-9-CM 571. Nonalcoholic steatohepatitis (NASH) is the inflammatory form of nonalcoholic fatty liver disease (NAFLD). The 2024 edition of ICD-10-CM K70. ICD-9-CM 571. K76. Nonalcoholic fatty liver disease is the accumulation of lipids in the liver above 5% of the total liver weight, in the absence of other medical conditions. Diagnoses and procedure codes appear in eTables 1-5 in Supplement 2. 223. doi: 10. When using code K70. e. 800-544-9144. Below are some of the ICD-10-CM Diagnosis codes that could potentially be assigned based on provider documentation. This test is a noninvasive assessment of liver status in patients with nonalcoholic fatty liver disease (NAFLD). 60,. 0 should only be used for claims with. There are two types; non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH), with the latter indicating the presence of further liver inflammation. 81 K75. 9 [convert to ICD-9-CM] Non-alcoholic fatty liver disease (NAFLD) consists of non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). 1–4 Steatosis and steatohepatitis are the most common morphologic patterns of liver injury in NAFLD patients. 2019;101:154005. We assess the impact of having NAFLD on adverse clinical outcomes and all-cause mortality for people with CKD. 81) ICD-10-CM Diagnosis Code K76. 8 (Other. 10 may differ. This is the American ICD-10-CM version of K74. Inflammation and liver cell damage can cause fibrosis, or scarring. Baicalin attenuates hepatic injury in non-alcoholic steatohepatitis cell model by suppressing inflammasome-dependent gsdmd-mediated cell pyroptosis. K75 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. ICD-10-CM Index; ICD-10-CM External Causes Index; Table of Drugs; Table of Neoplasms; Conversion; DRG; Rules . 01 Hepatic fibrosis, early fibrosis K74. 81 is a billable ICD code used to specify a diagnosis of nonalcoholic steatohepatitis (NASH). K75. 00 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. doi: 10. 00 Hepatic fibrosis, unspecified K74. Ini mencakup membatasi konsumsi lemak, memperbanyak konsumsi serat, mengendalikan kalori konsumsi makanan, dan meningkatkan aktivitas fisik. Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases, estimated to affect about 25% of the world population [1,2,3]. Nonalcoholic fatty liver disease (NAFLD) is increasing in prevalence worldwide. This is the American ICD-10-CM version of K74. 500 results found. Alcoholic cirrhosis of liver. Methods This prospective cohort study included 171,544 UK Biobank participants. Nonalcoholic steatohepatitis (NASH) is a type of nonalcoholic fatty liver disease (NAFLD). ICD-10-CM K75. Explore the Nonalcoholic Steatohepatitis (NASH) complications. 9 may differ. ICD-10-CM Codes; ICD-10-PCS Codes; Legacy ICD-9-CM Codes; Indexes . 9 - other international versions of ICD-10 K70. 4 Peliosis hepatis K76. org There are two forms of NAFLD: nonalcoholic fatty liver (NAFL), defined as 5% or greater hepatic steatosis without hepatocellular injury or fibrosis, and nonalcoholic steatohepatitis (NASH. Chronic hepatitis due to fatty liver; Fatty liver disease; Fatty liver disease, nonalcoholic; Hepatitis, chronic, due to fatty liver disease; Non-alcoholic fatty liver; Steatosis of liver; nonalcoholic steatohepatitis (NASH) (K75. Our large population database results emphasize that there is a significant association between OSA and NASH. The 2024 edition of ICD-10-CM K74. K76 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. in; a Local Coverage Determination (LCD) policy or Article ID; or a CPT/HCPCS procedure/billing code or an ICD-10-CM diagnosis code. It is unclear how progression of NAFLD towards cirrhosis. Lancet 358(9285):893–894, 2001. To date, there is no simple noninvasive test for diagnosing NASH. This topic will review the treatment and prognosis of NAFLD. 81) ICD-10-CM Diagnosis Code K74. This is the American ICD-10-CM version of K76. ICD-10-CM 2023 Coding Guide™ from Unbound Medicine. 0 - other international versions of ICD-10 K70. 0-) ICD-10-CM Diagnosis. The 2024 edition of ICD-10-CM K74. Nonalcohol-associated fatty liver disease (NAFLD) is a spectrum of disease characterized by hepatic steatosis in the absence of excessive alcohol consumption. ICD-9-CM Diagnosis Codes; ICD-9-Vol-3 Procedure Code; Search All Data; 2023/2024. 81 is a billable diagnosis code used to specify a medical diagnosis of nonalcoholic steatohepatitis (nash). Cirrhosis develops in 21% to 28 % of NASH patients compared to only 3% of patients with NAFL []. 81 [convert to ICD-9-CM] Nonalcoholic steatohepatitis (NASH) Nonalcoholic steatohepatitis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver); code, if applicable, hepatic fibrosis (K74. ICD-10-CM Diagnosis Code K70. NAFLD and NASH ICD-9-CM Codes and ICD-10-CM Codes. It is characterized by excessive hepatic fat accumulation, associated with insulin resistance and defined as the histological presence of steatosis in >5% hepatocytes. For non-alcoholic steatohepatitis (NASH) clinical trials, it has been defined as ongoing or recent consumption of more than 14 standard drinks on average per week in women and more than 21 standard drinks on average per week in men. 5 (Cirrhosis of liver without mention of alcohol), 571. Although, minor deposition of fat can occur in the liver of healthy adults, deposition of fat in at least 5% of hepatocytes is considered pathologic. The ethics committee of Istanbul Gelişim University approved this study (ethical code: 77366270-302. poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4 or 6); alcoholic liver disease (K70. NAFLD has a histologic spectrum ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), advanced fibrosis, and cirrhosis. 1. However, because this approach has several limitations,. 51 - other international versions of ICD-10 K71. Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the Western world, with an estimated prevalence of approximately 25% [1, 2]. This topic will review the treatment and prognosis of NAFLD. K00-K95. Occasionally there may be. The 2024 edition of ICD-10-CM K70. , 2016; Liu et al. ICD-9-CM 571. 114, Digestive System, Diagnostic Code 7345. 441 Disorders of liver except malignancy, cirrhosis or. 0001) and leads to the creation of a new independent. Patient Education. K75. The 2024 edition of ICD-10-CM K76. ECGs or ICD-9 code: Community-based 9333 individuals without baseline AF; aged 53–75 y: Prospective cohort: 12 y: Incident AF:. NAFLD: Non-alcoholic fatty liver disease, or NAFLD, is a collective term used to describe a group of conditions where there is an abnormal accumulation of fat in the liver in those who drink little to no alcohol. Nonalcoholic steatohepatitis (NASH) is a condition that causes inflammation and accumulation of fat and scar tissue in the liver. Background: The diagnosis of NASH needs a liver biopsy, an invasive procedure that is not frequently accepted by patients. INTRODUCTION. NAFLD/NASH cirrhosis may also attract code K74. Epidemiologic studies of alcoholic hepatitis (AH) have been hindered by the lack of a validated International Classification of Disease (ICD) coding algorithm for use with administrative data. org. DRG Group #441-443 - Disorders of liver except malig, cirr, alc hepa with MCC. Liver biopsy is the best way to diagnose NASH and clearly shows the amount of liver damage. Liver Diseases. 0. 08. Nonalcoholic fatty liver disease (NAFLD) affects one-fourth of the global population and is the most common cause of chronic liver disease. 0 became effective on October 1, 2023. The global prevalence of NAFLD was estimated to be about 24% []. NASH is falls within the large, overarching theme of non-alcoholic fatty liver disease (NAFLD. The following code (s) above K70. Clinical manifestations, diagnosis, and prognosis of primary biliary cholangitis; Diagnosis of hyperthyroidism; Enzymatic measures of cholestasis (eg, alkaline phosphatase, 5'-nucleotidase, gamma-glutamyl transpeptidase) Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adultsThis may range from a non-serious condition called fatty liver to a potentially serious condition called non-alcoholic steatohepatitis or NASH. It affects an estimated 20% of the general population, based on cohort studies of varying size and heterogeneous selection. A practical approach. 81, K76. 0-) ICD-10-CM Diagnosis Code K75. 0 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 571. 9 Inflammatory liver disease, unspecified;500 results found. The following code (s) above K70. K70. Background Chronic kidney disease (CKD) and non-alcoholic fatty liver disease (NAFLD) frequently co-exist. 8 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 571. It often develops due to a metabolic disorder, such as obesity or diabetes, resulting in a toxic buildup of fat in the liver. 9 may differ. Nonalcoholic fatty liver disease (NAFLD) is a spectrum of diseases ranging from simple hepatic steatosis to nonalcoholic steatohepatitis (NASH) to advanced fibrosis and cirrhosis as well as liver cancer. ICD 10 CM K75. In Asian countries, lifestyle changes have led to gradually increasing numbers of NAFLD and nonalcoholic steatohepatitis (NASH),. Nonalcoholic steatohepatitis (NASH) is a common but underappreciated liver disease. Steatohepatitis, nonalcoholic; Steatosis of liver; Yellow atrophy of liver, chronic; Applies To. Often there are no or few symptoms. 02 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. excessive alcohol consumption, medications, Wilson disease, or disorders of lipid metabolism) [Citation 1]. Alcoholic cirrhosis; Alcoholic cirrhosis of liver. HCCs; ICD-11 NEW; SNOMED CT NEW; ICD-9-CM;K70. Treatment. 5. 1 result found: ICD-10-CM Diagnosis Code K75. (NAFLD) can be daunting but watch how Shawanna met the challenge head on and is reversing her diagnosis with weight loss, healthy eating and exercise!Since the code for ICD-10 (International Classification of Diseases) does not have a single designation, today the most common encoding is K76. Nonalcoholic fatty liver disease (NAFLD) encompasses the entire spectrum of fatty liver disease in individuals without significant alcohol consumption, including isolated steatosis, steatohepatitis, and cirrhosis. 81 [convert to ICD-9-CM] Nonalcoholic steatohepatitis (NASH) Nonalcoholic steatohepatitis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver); code, if applicable, hepatic fibrosis (K74. 0. 9, K75. K73 Chronic hepatitis, not elsewhere classified. Inclusion ICD-9 code: In the ICD-9 branch of chronic liver disease (571) we will include 571. To prevent possible data-leakage, we only considered patient medical codes at least a month before the diagnosis of their respective ailment and manually deleted all medical codes corresponding to the diagnosis of NAFLD, NASH or liver biopsy test. FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. It accounts for about 20% of nonalcoholic steatohepatitis cases. This is the American ICD-10-CM version of K71. The main characteristic of NAFLD is considered that the excessive fat is accumulated and. The definitive diagnosis of non-alcoholic steatohepatitis was established using hepatic biopsy. Nonalcoholic steatohepatitis affects 3% to 6% of the US population, is more prevalent in patients with metabolic disease and obesity, progresses to cirrhosis in approximately 20% of cases, and is associated with increased rates of liver-specific and overall mortality. 10 became effective on October 1, 2023. 3: Hepatitis NOS:ICD-10-CM Diagnosis Code K74. K75 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. Lancet Gastroenterol. ICD-9-CM 571. 06–0. Opsi terapi Non-alcoholic Fatty Liver Disease (NAFLD) dan Non-alcoholic Steatohepatitis (NASH) saat ini dapat menggunakan pendekatan farmakologi dan nonfarmakologi. 0 - other international versions of ICD-10 K74. 8 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 571. 69 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Download the app!. AFFECTING UP TO 100 million people in the US and up to 35% of the population worldwide, nonalcoholic fatty liver disease (NAFLD) is defined as storage of excess fat in the liver not caused by heavy alcohol consumption. It is a liver disease from the family of NAFLD (non-alcoholic fatty liver. Chart review was completed, and consensus definitions were used to assign certainty of diagnosis. Zhang Y, Xing J, Liu L, Qiao F, Li J, et al. The diagnosis and management of non‐alcoholic fatty liver disease:. 81 [convert to ICD-9-CM] Nonalcoholic steatohepatitis (NASH) Nonalcoholic steatohepatitis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver); code, if applicable, hepatic fibrosis (K74. 81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. In addition, the presence of NAFLD is. K76 Other diseases of liver. ICD-9 Code ICD-9 Description; K75. K72 Hepatic failure, not elsewhere classified. Reliance on the biopsy, both as a requisite for study entry, as well as for a primary endpoint in clinical trials, poses several challenges. The main treatment option for steatohepatitis is lifestyle modification. n engl j med 377;21 nejm. 0 ‘Fatty (change of) liver, not elsewhere classified (non-alcoholic fatty liver disease)’. ; This is the American ICD-10-CM version of. Background Non-alcoholic steatohepatitis (NASH) is a progressive form of non-alcoholic fatty liver disease characterized by excessive liver fat accumulation, inflammation, cell injury, and fibrosis. 30 [convert to ICD-9-CM] Alcoholic cirrhosis of liver without ascites. 0 - other international versions of ICD-10 K70. 81 is a valid billable ICD-10 diagnosis code for Nonalcoholic steatohepatitis (NASH) . 02 [convert to ICD-9-CM] Hepatic fibrosis, advanced fibrosis. 2014. Mere deposition of fat in the liver is termed steatosis, and together these constitute fatty liver changes. NASH is characterized by steatosis accompanied by hepatocyte. 0) codes in the absence of any diagnosis codes for other common causes of chronic liver disease . Applicable To. Code History. 5 (Cirrhosis of liver without mention of alcohol), 571. Bariatric surgery is associated with reduction in non-alcoholic steatohepatitis and hepatocellular carcinoma: a propensity matched analysis. 0; Other cirrhosis of liver – K74. Quantitative results of 10 biochemicals in combination with age, gender, height, and weight are analyzed using a computational algorithm to provide a quantitative surrogate marker (0. e. According to a US population-based study of 3869 NAFLD patients and 15,209 controls, the incidence of NAFLD increased fivefold from 62 to 329 per 100,000 person-years between. doi:. 650-736-5555. (18–90 year) who had a diagnosis of OSA using the International Classification of Diseases ICD-9 codes. All tests were performed within a maximum of 72 h of each other, with the notable exception of the hepatic biopsy, which was performed within the previous 6-months. ICD-9-CM 571. Nonalcoholic steatohepatitis (NASH) K75. nonalcoholic steatohepatitis (NASH) alcoholic K70. Up to 1 in 7 people with NAFLD. Short description: Chronic liver dis NEC. Nonalcoholic steatohepatitis (NASH), a more serious form of the disease, occurs when, along with the fat build up, there is inflammation and subsequent irreversible damage to the liver. 2020 Dec;32(12):1566-1570. This list includes both the main, and any alternate names for each disease. 89 Other specified inflammatory liver diseases; K75. NAFLD is subdivided into nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). Nonalcohol-associated fatty liver disease (NAFLD) is a spectrum of disease characterized by hepatic steatosis in the absence of excessive alcohol consumption. Codes . 02 - other international versions of ICD-10 K74. Helpline 1-800-465-4837ICD-9-CM Diagnosis Codes; ICD-9-Vol-3 Procedure Code; Search All Data; 2023/2024. 7), defined as a fasting plasma glucose ≥ 110. 3, and V79. , 1980; Kleiner et al. Bile acids aggravate nonalcoholic steatohepatitis and cardiovascular disease in shrsp5/dmcr rat model. Nonalcoholic fatty liver disease (or NAFLD for short) is a buildup of fat in the liver that is not caused by drinking alcohol. The standard of care is represented by the lifestyle intervention. 8 ‘Other specified inflammatory liver diseases (non-alcoholic steatohepatitis)’ and K76. Short description: Ac alcoholic hepatitis. NASH has an estimated prevalence of 3% to 5% in the US general population. Non-alcoholic steatohepatitis (NASH), the more progressive form of NAFLD, is particularly challenging to diagnose in the absence of histology. 1. This is the first study using the ICD-10-CM code with a specific search code for NASH. Indeed, a recent meta-analysis. Browse by Disease. Nonalcoholic steatohepatitis (NASH) is a common but underappreciated liver disease. 2020. (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver. Noninvasive Assessment of Nonalcoholic Steatohepatitis (NASH) NASH is a serious condition that can progress to cirrhosis and its complications including portal hypertension and hepatocellular carcinoma [6, 12, 13]. 2298. Nonalcoholic Steatohepatitis (NASH): Treatment Test: 550960. The following code (s) above K70. It affects an estimated 20% of the general population, based on cohort studies of varying size and heterogeneous selection. NAFLD is associated with excess risk of all-cause mortality, and its progression to nonalcoholic steatohepatitis (NASH) and fibrosis accounts for a growing proportion of cirrhosis and hepatocellular cancer and thus is a leading cause of liver transplant. excessive alcohol consumption, medications, Wilson disease, or disorders of lipid metabolism) []. with a diagnosis of hepatic steatosis confirmed by biopsy when available. K74. 0-1. The lack of consensus on definitions threatens the comparability and generalizability of. The 2019 edition of ICD-10-CM K76. NAFLD was defined according to the International Classification of Disease, 9th Revision, Clinical Modification (ICD-9-CM) codes 571. Alcoholic cirrhosis with ascites; Ascites due to alcoholic cirrhosis. (ICD-9) codes. Nonalcoholic fatty liver disease (NAFLD) has become a serious public health issue not only in Western countries but also in Japan. However, there is general consensus that, for those patients who do progress to cirrhosis (fibrosis stage 4), there is an. Fibrosis scores included APRI, NFS, Fib-4, and. This ICD-10 code translates to more than one ICD-9 code: 571. The 2024 edition of ICD-10-CM K76 became effective on October 1, 2023. 571. Pendekatan nonfarmakologi terdiri atas modifikasi gaya hidupNASH - Nonalcoholic steatohepatitis (442685003); Nonalcoholic steatohepatitis (442685003); Non-alcoholic steatohepatitis (442685003) Definition. Nonalcoholic steatohepatitis (NASH) is the critical stage in the development of nonalcoholic fatty liver disease (NAFLD) from simple and reversible steatosis to irreversible cirrhosis and even hepatocellular carcinoma (HCC). underlying liver disease, such as: nonalcoholic steatohepatitis (NASH) (. S. The differential diagnoses of alcoholic hepatitis include nonalcoholic. 2) and other causes such as toxic hepatitis (573. 81. 60 became effective on October 1, 2023. The Hospital Discharge Abstract Database (DAD) was used to. Includes Excludes I Excludes II Notes From Section K70-K77:. Although noninvasive diagnosis of NAFLD/NASH has progressed, pathological evaluation of liver biopsy specimens remains the gold standard. NAFLD/NASH cirrhosis may also attract code K74. 11 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 0) of liver fibrosis (Metavir F0. [1][2][3] Although the exact cause of cryptogenic cirrhosis is unknown, there are correlations that non. Applicable To. 30 [convert to ICD-9-CM] Alcoholic cirrhosis of liver without ascites. 69 may differ. 0 became effective on October 1, 2023. 81 - Nonalcoholic steatohepatitis (NASH) answers are found in the ICD-10-CM powered by Unbound Medicine. Take steps toward getting a diagnosis by working with your doctor, finding the right specialists, and coordinating medical care. However, there is general consensus that, for those patients who do progress to cirrhosis (fibrosis stage 4), there is. Methods: We performed a prospective study on patients with. 8 ‘Other specified inflammatory liver diseases (non-alcoholic steatohepatitis)’ or K76. K70. Type 2 Excludes. 9, K75. It is found in the 2024 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2023 - Sep 30, 2024 . The gold standard for diagnosis of non-alcoholic steatohepatitis (NASH) and fibrosis is liver biopsy. 5 million persons from 22 countries. 30 [convert to ICD-9-CM] Alcoholic cirrhosis of liver without ascites. Metabolic dysfunction-associated steatohepatitis (MASH) is the replacement term for NASH. 1 is a non-billable code. Other inflammatory liver diseases. Showing 1-25: ICD-10-CM Diagnosis Code K70. 6 ‘Other and unspecified cirrhosis of liver’. The 2024 edition of ICD-10-CM K75 became effective on October 1, 2023.